Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Показать другие версии (1)

Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer�...

Полное описание

Библиографические подробности
Главные авторы:	Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A
Другие авторы:	International College of Geriatric Psychoneuropharmacology
Формат:	Journal article
Язык:	English
Опубликовано:	John Wiley & Sons, Ltd. 2010
Предметы:	Medical sciences Psychiatry

Схожие документы

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
по: Oulhaj, A, и др.
Опубликовано: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
по: Smith, A, и др.
Опубликовано: (2010)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
по: de Jager, C, и др.
Опубликовано: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
по: De Jager, C, и др.
Опубликовано: (2012)

Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
по: Goodwin, G
Опубликовано: (2003)

Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
по: Goodwin, G
Опубликовано: (2003)

Homocysteine, B vitamins, and cognitive impairment
по: Smith, A, и др.
Опубликовано: (2016)

Cholesterol-metabolism, plant sterols, and long-term cognitive decline in older people – Effects of sex and APOEe4
по: Matteo Spinedi, и др.
Опубликовано: (2024-02-01)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
по: Smith, A, и др.
Опубликовано: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
по: Smith, A, и др.
Опубликовано: (2010)

Homocysteine – A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia
по: Ines Elisabeth Futschek, и др.
Опубликовано: (2023-02-01)

Homocysteine, B vitamins, and cardiovascular disease
по: Refsum, H, и др.
Опубликовано: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
по: Refsum, H, и др.
Опубликовано: (2006)

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
по: Ballard, C, и др.
Опубликовано: (2008)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
по: Oulhaj, A, и др.
Опубликовано: (2016)

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
по: Martins, C, и др.
Опубликовано: (2005)

Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism
по: Fullerton, J, и др.
Опубликовано: (2003)

High dimensional endophenotype ranking in the search for major depression risk genes
по: Glahn, D, и др.
Опубликовано: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
по: De Jager, C, и др.
Опубликовано: (2012)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
по: Clarke, R, и др.
Опубликовано: (1998)

MET and autism susceptibility: family and case-control studies
по: Sousa, I, и др.
Опубликовано: (2009)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
по: Jones, S, и др.
Опубликовано: (2017)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
по: A David Smith, и др.
Опубликовано: (2010-09-01)

Investigating circadian disruption in mouse models of neurological and metabolic disorders
по: Livieratos, A
Опубликовано: (2013)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
по: Belbin, O, и др.
Опубликовано: (2009)

How can magnetoencephalography and magnetic resonance imaging improve our understanding of genetic susceptibility to Alzheimer's disease?
по: Heise, V
Опубликовано: (2013)

Psychiatric, demographic and personality characteristics of elderly sex offenders
по: Fazel, S, и др.
Опубликовано: (2002)

Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
по: Geetika Nehra, и др.
Опубликовано: (2025-01-01)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
по: Olivia M. Osborne, и др.
Опубликовано: (2023-08-01)

The cognitive neuropsychology of depression in the elderly
по: Herrmann, L, и др.
Опубликовано: (2007)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
по: Nurk, E, и др.
Опубликовано: (2005)

Using neuroimaging and histology to understand hyperexcitability and atypical connectivity in autism spectrum disorder
по: Ravishankar, M
Опубликовано: (2015)

Effect of physical activity on anxiety and depression in COVID-19 adults: A systematic review and meta-analysis
по: Qingyuan Luo, и др.
Опубликовано: (2024-10-01)

Caregiver Burden is Associated with Cognitive Decline and Physical Disability of Elderly Post-Stroke Patients
по: Othman, Zahiruddin, и др.
Опубликовано: (2014)

Validation of the Malay Version of Short Informant Questionnaire on Cognitive Decline in the Elderly (MS-IQCODE)
по: Othman, Zahiruddin, и др.
Опубликовано: (2015)

QEEG in affective disorder: about to be a biomarker, endophenotype and predictor of treatment response
по: Sermin Kesebir, и др.
Опубликовано: (2018-08-01)

Alzheimer's Disease - A Comprehensive Review
по: Kinga Woźniak, и др.
Опубликовано: (2024-02-01)

Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study
по: Luigi Zerbinati, и др.
Опубликовано: (2022-10-01)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
по: Refsum, H, и др.
Опубликовано: (2006)

Anti‐N‐homocysteine‐protein autoantibodies are associated with impaired cognition
по: Olga Włoczkowska, и др.
Опубликовано: (2021-01-01)